Global Blood Therapeutics Inc

FDA Filings

This page includes the latest FDA filings for Global Blood Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USANASDAQGBTDUNS 028636495
FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Global Blood Therapeutics Inc.
Prescription Medication2023-12-27
Global Blood Therapeutics Inc.
Prescription Medication2023-08-30
Global Blood Therapeutics Inc.
Prescription Medication2022-10-29
Global Blood Therapeutics Inc.
Prescription Medication2021-12-23
Global Blood Therapeutics Inc.
OXBRYTA2021-12-17
Global Blood Therapeutics Inc.
Prescription Medication2021-05-29
Global Blood Therapeutics Inc.
Prescription Medication2021-01-22
Global Blood Therapeutics Inc.
Prescription Medication2020-08-01
Global Blood Therapeutics Inc.
Prescription Medication2020-07-30
Global Blood Therapeutics Inc.
Prescription Medication2019-12-13
Global Blood Therapeutics Inc.
OXBRYTA2019-11-25
Global Blood Therapeutics Inc.
OXBRYTA2019-11-25

Similar & Related FDA Registered Companies

    Related Finance Registrations
    NCAGE Code75SU5GLOBAL BLOOD THERAPEUTICS, INC.!DBA GLOBAL BLOOD THERAPEUTICS
    CAGE Code75SU5GLOBAL BLOOD THERAPEUTICS, INC. GBT
    S.A.M. Registration75SU5 [28636495]GLOBAL BLOOD THERAPEUTICS, INC. GLOBAL BLOOD THERAPEUTICS
    DUNS028636495Global Blood Therapeutics, Inc.
    SEC0001629137Global Blood Therapeutics, Inc. of DELAWARE
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.